Evaluation of survivin mRNA antigen lipid nanoparticles and CTLA 4 inhibitor combination for effective oral carcinoma immunotherapy
| dc.contributor.author | K, Vandana | |
| dc.date.accessioned | 2026-07-17T10:37:58Z | |
| dc.date.issued | 2025 | |
| dc.description | Under the Supervision of Prof. Venkata Vamsi Krishna Venuganti | |
| dc.identifier.uri | https://shodhganga.inflibnet.ac.in/handle/10603/700511 | |
| dc.language.iso | en | |
| dc.publisher | BITS PILANI, Hyderabad campus | |
| dc.subject | PHARMACY | |
| dc.subject | Survivin mRNA antigen | |
| dc.subject | CTLA 4 inhibitor | |
| dc.subject | Oral carcinoma | |
| dc.title | Evaluation of survivin mRNA antigen lipid nanoparticles and CTLA 4 inhibitor combination for effective oral carcinoma immunotherapy | |
| dc.type | Thesis |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: